25.35
price down icon3.58%   -0.94
after-market Dopo l'orario di chiusura: 25.56 0.21 +0.83%
loading

Summit Therapeutics Inc Azioni (SMMT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
750.30%
568.44
66.85 65.82 58.11 59.78
Nonoperating Income/Loss
30.70%
2.729
3.938 13.10 2.124 -0.768
Income/Loss From Continuing Operations Before Tax
799.19%
-565.71
-62.91 -61.20 -56.25 -60.38
Income/Loss From Continuing Operations After Tax
799.19%
-565.71
-62.91 -61.20 -56.25 -60.38
Net Income/Loss
799.19%
-565.71
-62.91 -61.20 -56.25 -60.38
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.61%
742.62
738.08 6.3735 726.66 707.90
Diluted Average Shares
0.61%
742.62
738.08 6.3735 726.66 707.90
Basic Earnings Per Share
744.44%
-0.76
-0.09 -0.09 -0.08 -0.09
Diluted Earnings Per Share
744.44%
-0.76
-0.09 -0.09 -0.08 -0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.46
price up icon 0.64%
$36.00
price up icon 0.22%
$111.40
price down icon 1.02%
$127.21
price down icon 0.05%
biotechnology ONC
$312.51
price down icon 2.13%
Capitalizzazione:     |  Volume (24 ore):